How to Vet a Donor Egg Program

How do you vet a donor egg program?

You vet a donor egg program on transparency: whether it shows you its own outcomes, how thoroughly it screens and discloses donors, and whether it explains fresh versus frozen and the size of an egg cohort in writing rather than in a sales pitch. Good donor egg program vetting comes down to what the program will put on paper before you pay, and how well its answers match the way outcomes are actually reported and measured.

A program worth trusting answers the hard questions — outcomes, screening, and cohort terms — in writing, before you commit.

The rest of this walks through each question in turn: fresh or frozen eggs, how to read the success rates, how many eggs are in a cohort, what screening you are owed, and what a guarantee really covers. Cost is a separate discussion; the treatment pathway is too. This is about how to judge the program itself.

Fresh or frozen donor eggs?

Donor eggs come either fresh — retrieved from a donor and fertilized on a schedule synchronized with you — or frozen and thawed from an egg bank. Both are established, and a professional evidence review found that vitrified-oocyte outcomes can approach fresh-oocyte outcomes in favorable cases 1Ref 1Practice Committees of ASRM and SART (2021).Evidence-based outcomes after oocyte cryopreservation for donor oocyte in vitro fertilization and planned oocyte cryopreservation: a guideline.That vitrified (frozen) oocyte outcomes can approach fresh-oocyte outcomes in favorable cases, grounding the fresh-versus-frozen donor-egg comparison in evidence.. Frozen is more convenient and lets you buy a defined cohort; fresh can mean more eggs per cycle. Neither is automatically better, so the useful questions are about execution.

Vitrification is the flash-freezing method used to bank eggs and embryos.

Ask how the program vitrifies and warms eggs, what its warming survival rate is, and which embryology lab does the fertilization and culture. If you are weighing this against continuing with your own eggs, the comparison of own-egg vs donor-egg cumulative outcomes — and the threshold for moving to donor eggs — is its own decision that a good program will discuss honestly rather than steer.

How to read a donor program's success rates

Donor-egg cycles are reported separately from cycles using a patient's own eggs, because donor eggs are typically from young, screened donors and would otherwise inflate a clinic's overall numbers. National reporting breaks outcomes out this way and defines success in specific ways — per transfer, per intended retrieval, per patient, and cumulatively 2Ref 2Society for Assisted Reproductive Technology (SART) (2024).National Summary Report (SART CORS Online).That national ART outcomes are reported with donor cycles broken out separately and defined by specific denominators — per transfer, per intended retrieval, per patient, and cumulatively.. Federal law has required clinics to report success rates since 1992, and the data is published so you can compare rather than trust a single figure 3Ref 3Centers for Disease Control and Prevention (2024).ART Success Rates.That federal law mandates and publishes clinic-level assisted-reproduction success-rate reporting, which patients can use to compare programs..

The trap is the denominator. A live-birth rate per transfer looks higher than the same program's rate per cycle started, because it drops the cycles that never reached transfer. When you read donor-egg success rates, insist on knowing per cycle, per transfer, per retrieval — which denominator the number uses — and compare programs on the same one. A program that quotes only its most flattering per-transfer figure, without the fuller donor gamete reporting, is telling you less than it seems.

How many eggs are in a cohort?

With frozen donor eggs you are usually buying a defined cohort — a set number of eggs — and cohort size drives your odds. A systematic review found cumulative live-birth rates rise markedly when more mature oocytes are banked and when the eggs were frozen at a younger donor age 4Ref 4Hirsch A, et al. (2024).Planned oocyte cryopreservation: a systematic review and meta-regression analysis.That cumulative live-birth rates rise markedly when more mature oocytes are banked and when eggs are frozen at a younger age, making cohort size a key vetting question.. Not every egg survives warming, fertilizes, and becomes a usable embryo, so a small cohort can leave you with fewer embryos than the headline count suggests.

Cumulative live-birth rates climb with the number of mature eggs banked and a younger age at freezing 4Ref 4Hirsch A, et al. (2024).Planned oocyte cryopreservation: a systematic review and meta-regression analysis.That cumulative live-birth rates rise markedly when more mature oocytes are banked and when eggs are frozen at a younger age, making cohort size a key vetting question..

So the questions that matter are how many mature eggs the cohort guarantees, what happens if fewer survive warming or fertilize than expected, and whether the program will replace a cohort that underperforms. This is where egg quality vs quantity becomes concrete: quantity buys you chances, but only mature, viable eggs count.

Donor screening and what you're owed in writing

A serious program screens donors to established standards and discloses the results to you. That generally includes FDA donor-eligibility testing for infectious disease (with a quarantine period for frozen eggs), genetic carrier screening, a detailed personal and family medical history, and a psychological evaluation of the donor. What you are entitled to see, and in how much detail, is a fair thing to confirm before choosing a program.

Worth asking, specifically: what infectious-disease and genetic screening each donor undergoes, how family medical history is collected and verified, whether the donor's own reproductive outcomes are known, and how the program handles a health update from a donor after the fact. A program that treats these as reasonable questions, rather than proprietary secrets, is showing you how it will treat you throughout.

Guarantees and shared-risk programs

Donor programs often sell guarantee or shared-risk packages that promise a refund or repeat cycles if you do not have a baby. Professional ethics guidance holds these are acceptable only when success is defined in advance, when every cost and exclusion is disclosed, and when the program states its own success rates — and it flags the conflict of interest built into a program that keeps your money if you succeed early 5Ref 5Ethics Committee of ASRM (2023).Financial "risk-sharing" or refund programs in assisted reproduction: an Ethics Committee opinion.That guarantee and shared-risk programs are ethically acceptable only when success is defined in advance, all costs and exclusions are disclosed, and success rates are stated, and that they carry a built-in conflict of interest..

Read the same clauses you would in any refund program: what counts as 'success,' who qualifies and who is excluded, how many cycles or cohorts are covered, what is non-refundable, and what happens if you leave. The financial arithmetic of these packages belongs to a separate discussion, but the disclosure standard does not: if the definition of success is not in writing before you pay, that is the answer.

Add-ons: pay for what's proven

Donor-egg cycles attract the same menu of paid add-ons as any IVF cycle, and most of them are unproven. The UK regulator rates common IVF add-ons on a color-coded scale and finds that many lack good evidence of benefit and that some may cause harm, which means a standard cycle without extras is often the better value 6Ref 6Human Fertilisation and Embryology Authority (2024).Treatment add-ons with limited evidence.That many marketed IVF add-ons lack good evidence of benefit and some may cause harm, so a standard cycle without extras is often the better value.. Because donor eggs already come from young, screened donors, layering on treatments marketed to 'boost' an already-favorable cycle rarely has evidence behind it.

The practical move is to ask, for each add-on offered, what evidence supports it for donor-egg cycles specifically and what it costs. Keep the leftover-embryo picture in view too: successful cohorts often produce surplus embryos, and the resulting embryo storage fees are a real, recurring cost worth understanding before you start.